SPRT


Monday Morning Market Insights: KaloBios Pharmaceuticals Inc (KBIO), Chipotle Mexican Grill, Inc. (CMG), Celldex Therapeutics, Inc. (CLDX), Sarepta Therapeutics Inc (SRPT)

KaloBios Pharmaceuticals Inc (NASDAQ:KBIO) soaring 30% in early morning trading, adding to their 20% rise after Friday’s news that the company appointed Martin Shkreli as …

For Long-Term Investors We Would Recommend Buying Sarepta, Says Roth Capital

In a research note published yesterday, Roth Capital analyst Debjit Chattopadhyay reiterated a Buy rating on Sarepta Therapeutics (SRPT) with a $34 price …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts